Scribd Logo
Upload

Welcome to Scribd!

  • 169 views

    PPI Market Share in Bangladesh

    Uploaded by

    Lony
    The document shows the market share percentages of the top 5 acid pump inhibitor molecules (Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole, and Amoxicillin+Clarithromycin+Lansoprazole) for the top 10 pharmaceutical companies in Bangladesh over three time periods from June 2013 to June 2015. Healthcare had the highest market share for most molecules and companies, ranging from 20-30%.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    PPI Market Share in Bangladesh

    Uploaded by

    Lony
    169 views1 page
    The document shows the market share percentages of the top 5 acid pump inhibitor molecules (Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole, and Amoxicillin+Clarithromycin+Lansoprazole) for the top 10 pharmaceutical companies in Bangladesh over three time periods from June 2013 to June 2015. Healthcare had the highest market share for most molecules and companies, ranging from 20-30%.

    Original Description:

    PPI Market Share

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document shows the market share percentages of the top 5 acid pump inhibitor molecules (Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole, and Amoxicillin+Clarithromycin+Lansoprazole) for the top 10 pharmaceutical companies in Bangladesh over three time periods from June 2013 to June 2015. Healthcare had the highest market share for most molecules and companies, ranging from 20-30%.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    169 views1 page

    PPI Market Share in Bangladesh

    Uploaded by

    Lony
    The document shows the market share percentages of the top 5 acid pump inhibitor molecules (Omeprazole, Esomeprazole, Pantoprazole, Rabeprazole, and Amoxicillin+Clarithromycin+Lansoprazole) for the top 10 pharmaceutical companies in Bangladesh over three time periods from June 2013 to June 2015. Healthcare had the highest market share for most molecules and companies, ranging from 20-30%.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    5.

    00%

    5.00%

    0.00%
    0.00%

    0.00%

    30.00%
    30.00%

    HEALTHCARE
    30.00%

    25.00%
    25.00%

    25.00%

    20.00%
    20.00%
    20.00%

    15.00%
    15.00%
    15.00%

    10.00%
    10.00%
    10.00%

    5.00%
    5.00%
    5.00%

    0.00%
    0.00%

    0.00%

    A.C.I.

    30.00%

    30.00%
    30.00%

    25.00%
    25.00%

    25.00%

    20.00%
    20.00%

    20.00%

    15.00%
    15.00%

    15.00%

    10.00%
    10.00%
    10.00%

    5.00%

    5.00%
    5.00%

    0.00%

    0.00%
    0.00%

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    10.00%

    5.00%

    BEXIMCO

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    10.00%

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    15.00%

    10.00%

    RABEPRAZOLE

    15.00%

    RABEPRAZOLE

    20.00%

    15.00%

    RABEPRAZOLE

    25.00%

    20.00%

    PANTOPRAZOLE

    25.00%

    20.00%

    PANTOPRAZOLE

    25.00%

    PANTOPRAZOLE

    30.00%

    ESOMEPRAZOLE

    INCEPTA

    ESOMEPRAZOLE

    OMEPRAZOLE

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    RABEPRAZOLE

    PANTOPRAZOLE

    30.00%

    ESOMEPRAZOLE

    OMEPRAZOLE

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    RABEPRAZOLE

    PANTOPRAZOLE

    ESOMEPRAZOLE

    OMEPRAZOLE

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    30.00%

    OMEPRAZOLE

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    RABEPRAZOLE

    ARISTO

    PANTOPRAZOLE

    ESKAYEF

    ESOMEPRAZOLE

    OMEPRAZOLE

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    RABEPRAZOLE

    PANTOPRAZOLE

    ESOMEPRAZOLE

    OMEPRAZOLE

    SQUARE

    ESOMEPRAZOLE

    OMEPRAZOLE

    AMOXICILLIN+
    CLARITHROMYCIN+
    LANSOPRAZOLE

    RABEPRAZOLE

    MAT ~ 06/2014

    RABEPRAZOLE

    PANTOPRAZOLE

    ESOMEPRAZOLE

    OMEPRAZOLE

    MAT ~ 06/2015

    PANTOPRAZOLE

    ESOMEPRAZOLE

    OMEPRAZOLE

    ACID PUMP INHIBITORS

    TOP 10 COMPANY'S WITH TOP 5 MOLECULE'S MARKET SHARE


    RENATA

    MAT ~ 06/2013

    OPSONIN

    You might also like